Literature DB >> 8464434

The occurrence of sleep-disordered breathing among middle-aged adults.

T Young1, M Palta, J Dempsey, J Skatrud, S Weber, S Badr.   

Abstract

BACKGROUND: Limited data have suggested that sleep-disordered breathing, a condition of repeated episodes of apnea and hypopnea during sleep, is prevalent among adults. Data from the Wisconsin Sleep Cohort Study, a longitudinal study of the natural history of cardiopulmonary disorders of sleep, were used to estimate the prevalence of undiagnosed sleep-disordered breathing among adults and address its importance to the public health.
METHODS: A random sample of 602 employed men and women 30 to 60 years old were studied by overnight polysomnography to determine the frequency of episodes of apnea and hypopnea per hour of sleep (the apnea-hypopnea score). We measured the age- and sex-specific prevalence of sleep-disordered breathing in this group using three cutoff points for the apnea-hypopnea score (> or = 5, > or = 10, and > or = 15); we used logistic regression to investigate risk factors.
RESULTS: The estimated prevalence of sleep-disordered breathing, defined as an apnea-hypopnea score of 5 or higher, was 9 percent for women and 24 percent for men. We estimated that 2 percent of women and 4 percent of men in the middle-aged work force meet the minimal diagnostic criteria for the sleep apnea syndrome (an apnea-hypopnea score of 5 or higher and daytime hypersomnolence). Male sex and obesity were strongly associated with the presence of sleep-disordered breathing. Habitual snorers, both men and women, tended to have a higher prevalence of apnea-hypopnea scores of 15 or higher.
CONCLUSIONS: The prevalence of undiagnosed sleep-disordered breathing is high among men and is much higher than previously suspected among women. Undiagnosed sleep-disordered breathing is associated with daytime hypersomnolence.

Entities:  

Mesh:

Year:  1993        PMID: 8464434     DOI: 10.1056/NEJM199304293281704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  2000 in total

1.  Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients.

Authors:  T Young; L Finn
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Sleep apnoea and autonomic function.

Authors:  C W Zwillich
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  Sleep apnoea in women.

Authors:  N Edwards; I Wilcox; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

5.  The study of human sleep: a historical perspective.

Authors:  W C Dement
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 6.  Sleep apnoea and snoring: potential links with vascular disease.

Authors:  C E Sullivan; S G McNamara
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 7.  Pediatric origins of adult lung diseases. 3: the genesis of adult sleep apnoea in childhood.

Authors:  F McNamara; C E Sullivan
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 8.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

9.  Cigarette smoking behavior and respiratory alterations during sleep in a healthy population.

Authors:  Gonzalo G Casasola; José L Alvarez-Sala; José A Marques; José M F Sánchez-Alarcos; Donald P Tashkin; Domingo Espinós
Journal:  Sleep Breath       Date:  2002-03       Impact factor: 2.816

10.  Subgrouping persons with snoring and/or apnea by using anthropometric and cephalometric measures.

Authors:  M G Hans; S Nelson; N Pracharktam; S J Baek; K Strohl; S Redline
Journal:  Sleep Breath       Date:  2001-06       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.